UNSPSC 85814912: Introduction of oxazolidinones into male reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into male reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0N328

UNSPSC 85814912 (Introduction of oxazolidinones into male reproductive, percutaneous approach) is a Commodity code that shows a fundamental mismatch between its medical taxonomy designation and actual state and local procurement activity. The recent opportunities posted under this code do not address the specific pharmaceutical procedure or intervention the code describes; instead, they span a broad range of health services including telehealth urgent care, employee occupational health, cancer screening, PACE operations, medical director services, mental health and addiction treatment, forensic psychological evaluation, wellness platforms, and inmate healthcare. State and local issuers—including health authorities in Nevada, county health systems in California and Georgia, municipal health departments, school districts, and specialized state facilities—are using this code as a catch-all taxonomy entry rather than for the oxazolidinone procedure itself. The mismatch signals either misclassification by posting agencies or an outdated or inappropriately broad code assignment by procurement platforms.

The geographic spread of recent activity extends across California (San Mateo, Inland Empire), Nevada, Georgia (DeKalb, Forsyth, Cobb), Arizona, Colorado, Texas, Florida, New Jersey, New York, Oregon, Kansas, Illinois, and Washington, D.C.—indicating nationwide fragmentation with no dominant jurisdiction. Representative solicitations include the Nevada Health Authority's PACE RFP (41NHA-S4038, proposals due December 10, 2026) seeking operators for statewide senior care programs with fixed monthly capitation rates ranging from $4,532.24 to $8,804.32 per participant depending on county and eligibility; the San Mateo County cancer registry services RFP (660002627262, proposals due October 12, 2026) offering local vendor preferences and targeting annual casefinding of approximately 1,000 records; and the Inland Empire Health Plan's RFI for virtual urgent care (Solicitation 2607426, due October 31, 2026) gathering market intelligence on 24/7/365 telehealth capabilities for a California-based member population. Code activity reflects current state and local health procurement priorities—chronic disease management, population health technology, occupational health, and behavioral health services—but does not meaningfully track procurement under the Commodity code's stated scope. Business development professionals should verify code classification with issuing bodies before relying on this taxonomy tier to identify relevant opportunities in pharmaceutical intervention services.